Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gliomas
Biotech
Day One jets off with Sprint's VRK1 program for up to $316M
Cruising on the midstage clinical success of a brain cancer therapy, Day One is using the wind at its sails to bolster the back of its pipeline.
Max Bayer
Aug 16, 2023 10:47am
ASCO: Servier finds survival benefit in difficult brain cancer
Jun 5, 2023 8:55am
DeepGlioma AI classifies brain tumors within 90 seconds: study
Mar 27, 2023 8:15am
Servier’s $1.8B bet on Agios delivers phase 3 brain tumor win
Mar 14, 2023 10:15am
Good day for Day One as pediatric brain tumor drug proves worth
Jan 9, 2023 11:43am